Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity

While a number of therapeutic options to control the progression of human immunodeficiency virus (HIV-1) now exist, a broadly effective preventive vaccine is still not available. Through detailed structural analysis of antibodies able to induce potent effector cell activity, a number of Env epitopes...

Full description

Bibliographic Details
Main Authors: William D. Tolbert, Rebekah T. Sherburn, Verna Van, Marzena Pazgier
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Viruses
Subjects:
HIV
A32
C11
Online Access:http://www.mdpi.com/1999-4915/11/1/69
id doaj-1ed7627c20e645748a91956324c92970
record_format Article
spelling doaj-1ed7627c20e645748a91956324c929702020-11-24T23:14:18ZengMDPI AGViruses1999-49152019-01-011116910.3390/v11010069v11010069Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell ActivityWilliam D. Tolbert0Rebekah T. Sherburn1Verna Van2Marzena Pazgier3Infectious Diseases Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USAInfectious Diseases Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USADepartment of Biochemistry and Molecular Biology of University of Maryland School of Medicine, Baltimore, MD 21201, USAInfectious Diseases Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USAWhile a number of therapeutic options to control the progression of human immunodeficiency virus (HIV-1) now exist, a broadly effective preventive vaccine is still not available. Through detailed structural analysis of antibodies able to induce potent effector cell activity, a number of Env epitopes have been identified which have the potential to be considered vaccine candidates. These antibodies mainly target the gp120 Cluster A region which is only exposed upon viral binding to the target cell with epitopes becoming available for antibody binding during viral entry and fusion and, therefore, after the effective window for neutralizing antibody activity. This review will discuss recent advances in the structural characterization of these important targets with a special focus on epitopes that are involved in Fc-mediated effector function without direct viral neutralizing activities.http://www.mdpi.com/1999-4915/11/1/69HIVstructureADCCvaccineA32C11
collection DOAJ
language English
format Article
sources DOAJ
author William D. Tolbert
Rebekah T. Sherburn
Verna Van
Marzena Pazgier
spellingShingle William D. Tolbert
Rebekah T. Sherburn
Verna Van
Marzena Pazgier
Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
Viruses
HIV
structure
ADCC
vaccine
A32
C11
author_facet William D. Tolbert
Rebekah T. Sherburn
Verna Van
Marzena Pazgier
author_sort William D. Tolbert
title Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
title_short Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
title_full Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
title_fullStr Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
title_full_unstemmed Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
title_sort structural basis for epitopes in the gp120 cluster a region that invokes potent effector cell activity
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2019-01-01
description While a number of therapeutic options to control the progression of human immunodeficiency virus (HIV-1) now exist, a broadly effective preventive vaccine is still not available. Through detailed structural analysis of antibodies able to induce potent effector cell activity, a number of Env epitopes have been identified which have the potential to be considered vaccine candidates. These antibodies mainly target the gp120 Cluster A region which is only exposed upon viral binding to the target cell with epitopes becoming available for antibody binding during viral entry and fusion and, therefore, after the effective window for neutralizing antibody activity. This review will discuss recent advances in the structural characterization of these important targets with a special focus on epitopes that are involved in Fc-mediated effector function without direct viral neutralizing activities.
topic HIV
structure
ADCC
vaccine
A32
C11
url http://www.mdpi.com/1999-4915/11/1/69
work_keys_str_mv AT williamdtolbert structuralbasisforepitopesinthegp120clusteraregionthatinvokespotenteffectorcellactivity
AT rebekahtsherburn structuralbasisforepitopesinthegp120clusteraregionthatinvokespotenteffectorcellactivity
AT vernavan structuralbasisforepitopesinthegp120clusteraregionthatinvokespotenteffectorcellactivity
AT marzenapazgier structuralbasisforepitopesinthegp120clusteraregionthatinvokespotenteffectorcellactivity
_version_ 1725595110909935616